Current Status Of Antiangiogenic Factors
- 1 June 2000
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 109 (3) , 477-489
- https://doi.org/10.1046/j.1365-2141.2000.01864.x
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Zinc-Binding of Endostatin Is Essential for Its Antiangiogenic ActivityBiochemical and Biophysical Research Communications, 1998
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- PaclitaxelDrugs, 1994
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B?-hemolytic streptococcusZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Interleukin-4 is a potent mitogen for capillary endotheliumBiochemical and Biophysical Research Communications, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990